Mediclinic International PLC (LON:MDC) had its price target trimmed by Macquarie from GBX 970 ($12.12) to GBX 830 ($10.37) in a research report sent to investors on Wednesday. The brokerage currently has a neutral rating on the stock.

A number of other research firms also recently issued reports on MDC. Credit Suisse Group AG cut their price target on Mediclinic International PLC from GBX 1,120 ($13.99) to GBX 1,045 ($13.06) and set an outperform rating for the company in a research note on Friday, November 11th. Citigroup Inc. downgraded Mediclinic International PLC to a neutral rating and set a GBX 1,090 ($13.62) price target for the company. in a research note on Monday, September 12th. HSBC cut their price target on Mediclinic International PLC from GBX 920 ($11.49) to GBX 745 ($9.31) and set a reduce rating for the company in a research note on Friday, November 11th. Jefferies Group cut their price target on Mediclinic International PLC from GBX 833 ($10.41) to GBX 812 ($10.14) and set a hold rating for the company in a research note on Wednesday, September 28th. Finally, JPMorgan Chase & Co. reiterated a neutral rating and set a GBX 1,160 ($14.49) price target on shares of Mediclinic International PLC in a research note on Tuesday, August 23rd. One research analyst has rated the stock with a sell rating, seven have assigned a hold rating and two have issued a buy rating to the company’s stock. The company presently has an average rating of Hold and an average target price of GBX 941.22 ($11.76).

Analyst Recommendations for Mediclinic International PLC (LON:MDC)

Mediclinic International PLC (LON:MDC) opened at 724.00 on Wednesday. Mediclinic International PLC has a 52-week low of GBX 723.00 and a 52-week high of GBX 1,125.00. The firm’s market cap is GBX 5.34 billion. The stock has a 50 day moving average price of GBX 861.07 and a 200 day moving average price of GBX 952.14.

The company also recently announced a dividend, which will be paid on Monday, December 12th. Shareholders of record on Thursday, November 24th will be given a dividend of GBX 3.20 ($0.04) per share. The ex-dividend date is Thursday, November 24th. This represents a dividend yield of 0.41%.

TRADEMARK VIOLATION WARNING: This article was first published by The Cerbat Gem and is the sole property of of The Cerbat Gem. If you are reading this article on another website, it was stolen and republished in violation of United States & international copyright laws. The correct version of this article can be viewed at https://www.thecerbatgem.com/2016/11/24/mediclinic-international-plc-mdc-price-target-cut-to-gbx-830-by-analysts-at-macquarie.html.

Mediclinic International PLC Company Profile

Mediclinic International plc, formerly Al Noor Hospitals Group plc, is a holding company. The Company operates as an international private healthcare provider. Its segments include Mediclinic Southern Africa, Mediclinic Switzerland, Mediclinic Middle East, United Kingdom and Corporate. It focuses on providing acute care and multidisciplinary healthcare services.

Receive News & Stock Ratings for Mediclinic International PLC Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Mediclinic International PLC and related stocks with our FREE daily email newsletter.